Lilly sues vendors over copycat weight-loss drugs Reuters
If the litigation progresses to expert testimony and case-specific discovery, juries may not be sympathetic to a company that downplays catastrophic injuries as just a coincidence
Researchers at University of California San Diego School of Medicine have reported results from a large international clinical trial showing that semaglutide, a medication in the GLP-1 class of drugs widely used to treat diabetes and obesity, may help reduce liver scarring in patients with advanced fatty liver disease, including those with early-stage cirrhosis
The most clinically relevant efficacy data came from METAOD005, a 12-week randomized double-blind placebo-controlled study
DAILY BRAIN WELLNESS Formulated for busy professionals, students, and healthy aging adults looking to maintain memory, focus, and cognitive wellness as part of an active lifestyle
Of course, there can be nuances